{"id":76034,"date":"2026-10-07T13:58:18","date_gmt":"2026-10-07T13:58:18","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76034"},"modified":"2026-10-07T14:00:11","modified_gmt":"2026-10-07T14:00:11","slug":"johnson-johnson-jnj-rbc-update-stock-analysis","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/","title":{"rendered":"Johnson &#038; Johnson (JNJ): RBC Update &#038; Stock Analysis"},"content":{"rendered":"<h2><a href=\"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76034&amp;preview=true\">Johnson &amp; Johnson (JNJ)<\/a><\/h2>\n<p>RBC Capital Markets recently updated their coverage on JNJ&#8217;s stock, and\u00a0 maintained their &#8220;Outperform&#8221; rating and raised its 12 month price target to US$290 per share.<\/p>\n<h2>Operating Performance and Earnings Outlook<\/h2>\n<p>Johnson &amp; Johnson&#8217;s second-quarter 2026 results reported sales of US$25.3 billion, up 6.6%, diluted EPS of US$2.27 and adjusted EPS of US$2.90. The company raised its full-year outlook to a reported-sales midpoint of US$101.1 billion and an adjusted-EPS midpoint of US$11.68. Adjusted EPS is a non-GAAP measure, and guidance is management&#8217;s forecast.<\/p>\n<p>The investment case depends on durable growth across innovative medicines and medical technology. New products must contribute enough earnings to offset competitive pressure on established treatments. For shareholders, sales growth is most valuable when it supports sustainable profit and cash generation.<\/p>\n<h2>Valuation and Key Risks<\/h2>\n<p>The constructive scenario assumes successful commercialization and steady MedTech demand. A cautious scenario includes slower adoption, pricing pressure, patent-related competition or adverse legal outcomes. A premium valuation requires confidence that earnings can remain resilient beyond one forecast year.<\/p>\n<h2>Stock Analysis Outlook<\/h2>\n<p>Johnson &amp; Johnson\u2019s stock forecast is cautiously positive, with a &#8220;Buy&#8221; analyst consensus rating and a US$280 12 month price target, implying 10% upside. However, the &#8220;Strong Sell&#8221; technical signal suggests near-term weakness, creating a divide between analysts\u2019 positive outlook and current price momentum.<\/p>\n<p><small><a href=\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-updates\/\">More StockTargetAdvisor analyst updates<\/a>.<\/small><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Johnson &amp; Johnson (JNJ) RBC Capital Markets recently updated their coverage on JNJ&#8217;s stock, and\u00a0 maintained their &#8220;Outperform&#8221; rating and raised its 12 month&hellip;<\/p>\n","protected":false},"author":3,"featured_media":36987,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10580],"tags":[11260,7324,11261,2215],"class_list":["post-76034","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-analyst-updates","tag-jnj","tag-johnson-johnson","tag-stock-forecast"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Johnson &amp; Johnson (JNJ): RBC Update &amp; Stock Analysis | Stock Target Advisor<\/title>\n<meta name=\"description\" content=\"Johnson &amp; Johnson analyst update: RBC lifts its target to $290. Review healthcare growth, adjusted earnings, valuation and principal stock risks.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson &amp; Johnson (JNJ): RBC Update &amp; Stock Analysis\" \/>\n<meta property=\"og:description\" content=\"Johnson &amp; Johnson analyst update: RBC lifts its target to $290. Review healthcare growth, adjusted earnings, valuation and principal stock risks.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-07T13:58:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-07T14:00:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/07\/STA-Frame-9.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"Johnson &#038; Johnson (JNJ): RBC Update &#038; Stock Analysis\",\"datePublished\":\"2026-10-07T13:58:18+00:00\",\"dateModified\":\"2026-10-07T14:00:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/\"},\"wordCount\":224,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"keywords\":[\"analyst updates\",\"JNJ\",\"Johnson &amp; Johnson\",\"stock forecast\"],\"articleSection\":[\"Latest News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/\",\"name\":\"Johnson & Johnson (JNJ): RBC Update & Stock Analysis | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-07T13:58:18+00:00\",\"dateModified\":\"2026-10-07T14:00:11+00:00\",\"description\":\"Johnson & Johnson analyst update: RBC lifts its target to $290. Review healthcare growth, adjusted earnings, valuation and principal stock risks.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson &#038; Johnson (JNJ): RBC Update &#038; Stock Analysis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Johnson & Johnson (JNJ): RBC Update & Stock Analysis | Stock Target Advisor","description":"Johnson & Johnson analyst update: RBC lifts its target to $290. Review healthcare growth, adjusted earnings, valuation and principal stock risks.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/","og_locale":"en_US","og_type":"article","og_title":"Johnson & Johnson (JNJ): RBC Update & Stock Analysis","og_description":"Johnson & Johnson analyst update: RBC lifts its target to $290. Review healthcare growth, adjusted earnings, valuation and principal stock risks.","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-07T13:58:18+00:00","article_modified_time":"2026-10-07T14:00:11+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/07\/STA-Frame-9.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"Johnson &#038; Johnson (JNJ): RBC Update &#038; Stock Analysis","datePublished":"2026-10-07T13:58:18+00:00","dateModified":"2026-10-07T14:00:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/"},"wordCount":224,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"keywords":["analyst updates","JNJ","Johnson &amp; Johnson","stock forecast"],"articleSection":["Latest News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/","name":"Johnson & Johnson (JNJ): RBC Update & Stock Analysis | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-07T13:58:18+00:00","dateModified":"2026-10-07T14:00:11+00:00","description":"Johnson & Johnson analyst update: RBC lifts its target to $290. Review healthcare growth, adjusted earnings, valuation and principal stock risks.","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/johnson-johnson-jnj-rbc-update-stock-analysis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Johnson &#038; Johnson (JNJ): RBC Update &#038; Stock Analysis"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76034"}],"version-history":[{"count":5,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76034\/revisions"}],"predecessor-version":[{"id":76076,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76034\/revisions\/76076"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/36987"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}